Dr. William R. Hiatt and Dr. C. Michael Gibson Discuss: The Benefit And Risk Of Rivaroxaban Plus Aspirin In Patients With Peripheral Artery Disease After Lower Extremity Revascularization (ler) With And Without Concomitant Clopidogrel: A Key Subgroup Analysis From Voyager-pad